Article

A Prescription for Active Surveillance of Prostate Cancer

Leonard Gomella, chair of the urology department and director of the Kimmel Cancer Center Network, explains active surveillance when it comes to a prostate cancer diagnosis.

Leonard Gomella, chair of the urology department and director of the Kimmel Cancer Center Network at Jefferson University Hospitals, explains active surveillance when it comes to a prostate cancer diagnosis.

"Not all patients with prostate cancer require aggressive treatment," he says. "If, in meeting with your doctor, they discuss with you active surveillance versus actively treating the tumor, they need to really explain to you what active surveillance is. It's not that they're ignoring you, but it's keeping an eye on the cancer."

Active surveillance may be different for each practice, but "in general, it's a PSA (prostate-specific antigen test) and a rectal exam about every six month, and every year or two a biopsy of the prostate," he says.

Related Videos
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
Image of woman.
Image of woman.
Image of woman.
Image of man wearing baseball cap backwards.
Image of smiling doctor.
Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.
Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.
Image od grey haired Doctor.
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.